CellWell record HH-518647
Orlistat: a comprehensive review of a lipase inhibitor from obesity management to emerging oncological applications
Li Li; Yuchao Hao
2026
In plain language
This review of a lipase inhibitor reports associations with weight loss and reduced diabetes progression risk, plus emerging preclinical evidence of possible anti-cancer effects via fatty acid synthase inhibition.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-518647
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.